Biomea Fusion Statistics

Total Valuation

Biomea Fusion has a market cap or net worth of $66.50 million. The enterprise value is $33.31 million.

Market Cap	66.50M
Enterprise Value	33.31M

Important Dates

The last earnings date was Monday, May 5, 2025, after market close.

Earnings Date	May 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Biomea Fusion has 37.57 million shares outstanding. The number of shares has increased by 1.70% in one year.

Current Share Class	37.57M
Shares Outstanding	37.57M
Shares Change (YoY)	+1.70%
Shares Change (QoQ)	+1.00%
Owned by Insiders (%)	12.25%
Owned by Institutions (%)	55.17%
Float	29.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.13
P/TBV Ratio	2.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.28.

Current Ratio	2.25
Quick Ratio	1.81
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -156.81% and return on invested capital (ROIC) is -90.62%.

Return on Equity (ROE)	-156.81%
Return on Assets (ROA)	-74.21%
Return on Invested Capital (ROIC)	-90.62%
Return on Capital Employed (ROCE)	-376.65%
Revenue Per Employee	n/a
Profits Per Employee	-$1.21M
Employee Count	106
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -83.38% in the last 52 weeks. The beta is -0.08, so Biomea Fusion's price volatility has been lower than the market average.

Beta (5Y)	-0.08
52-Week Price Change	-83.38%
50-Day Moving Average	2.20
200-Day Moving Average	5.50
Relative Strength Index (RSI)	42.91
Average Volume (20 Days)	719,661

Short Selling Information

The latest short interest is 9.97 million, so 26.52% of the outstanding shares have been sold short.

Short Interest	9.97M
Short Previous Month	9.63M
Short % of Shares Out	26.52%
Short % of Float	33.90%
Short Ratio (days to cover)	12.80

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-132.72M
Pretax Income	-139.65M
Net Income	-128.63M
EBITDA	-130.93M
EBIT	-132.72M
Earnings Per Share (EPS)	-$3.54

Full Income Statement

Balance Sheet

The company has $35.86 million in cash and $7.93 million in debt, giving a net cash position of $27.94 million or $0.74 per share.

Cash & Cash Equivalents	35.86M
Total Debt	7.93M
Net Cash	27.94M
Net Cash Per Share	$0.74
Equity (Book Value)	28.74M
Book Value Per Share	0.76
Working Capital	24.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$113.53 million and capital expenditures -$327,000, giving a free cash flow of -$113.86 million.

Operating Cash Flow	-113.53M
Capital Expenditures	-327,000
Free Cash Flow	-113.86M
FCF Per Share	-$3.03

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biomea Fusion does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.70%
Shareholder Yield	-1.70%
Earnings Yield	-210.03%
FCF Yield	-185.91%

Analyst Forecast

The average price target for Biomea Fusion is $27.60, which is 1,459.32% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$27.60
Price Target Difference	1,459.32%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-8.77%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1